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There is considerable interest concerning the pathological consequences of aber-
rant expression of HLA-DR (class II) MHC products on endocrine cells from pa-
tients with autoimmune diseases such as insulin-dependent diabetes mellitus (1) .
The significance ofMHC gene expression in pancreatic islet cellsremains controversial
(2) . Normally, pancreatic (3 cells of mice constitutively express low levels of class I,
but do not express class II antigens (3) . In Non-Obese Diabetic (NOD)' mice,
which spontaneously develop autoimmune insulin-dependent diabetes, there have
been conflicting reports as to whether I-A antigens are constitutively expressed on
a cells (4, 5) . Similar controversy exists for other inbred strains . The situation in
situ is complicated by the finding that intra-islet macrophages (MO) phagocytosing
,Q cell cytoplasm stain positive for both insulin and I-A (6) . Diabetes induced by
multi-dose streptozotocin in CBA/Wehi (7) and C57BL/KsJ (8) male mice is as-
sociated with an increase in cells expressing class II MHC antigens on their sur-
faces ; in the case ofC57BL/KsJ mice, infiltrating Mo and not 0 cells comprise the
I-A + cells (8) . Momburg et al . (9) did not observe I-A antigens on islets from
B10.BR mice after in vivo treatment withIFN-y . However, Wright et al . (10) reported
induction of I-A' on free-floating islet preparations from B10.BR (H-2~) donors cul-
tured in the presence of IFN-y. Islet cell monolayers from CBA/Wehi (also H-2k)
cultured in the presence of high concentrations of IFN-y did not express class II
unlessTNFa was also included (11) . In this report, weshow that gene(s) in the CBA/J
inbred strain background exert trans-suppressive control over islet-specific class II
gene expression in the diabetes-susceptibleNOD inbred background . In the course
of these studies, an unexpected IFN-y inducible ("occult") expression ofaclass I-like
cell surface antigen was also discovered that may be of potential pathogenetic
significance in the autoimmune diabetes of NOD/Lt mice .
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OCCULT CLASS I-LIKE ANTIGEN IN NOD/Lt MICE
Materials and Methods
Mice.
￿
Non-Obese Diabetic (NOD/Lt) and Non-Obese Normal (NON/Lt) mice, including
hybrid crosses, were bred in our research colony from breeding pairs kindly provided by Dr.
Masakuzu Hattori (Joslin Diabetes Center, Boston, MA). CBA/J were obtained from the
-Animal Resources Unit of The Jackson Laboratory. All mice were maintained in a specific
pathogen-free facility on a 14:10 light/dark cycle, and allowed free access to food (diet 96W;
Emory Morse Co., Guilford, CT) and chlorinated drinking water.
mAbs and Antisera.
￿
Both NOD and NON mice possess recombinant MHC haplotypes that
appear unique and to which formal haplotype designations have not yet been assigned. The
H-2 complex of NOD is K° I-An,,l I-E° Db; that of NON is K° I-A-4 1-P-l'k' D'' (12). CBA/J
mice have a standard H-2'f haplotype. The 28-13-3 mAb (13) was used at a 1/4,000 dilution
to detect H-2K6 on NON/Lt cells and an IFN-y-inducible crossreactive class I-like antigen
on NOD/Lt cellsin culture. This mAb defines public specificity H-2 .39, an allodeterminant
in the second (Cl) external domain shaped by the H-2K° and H-2Kf haplotypes (14). The
31-3-4 mAb (15) was used at a 1/5 dilution to detect H-2K` expressed on NOD/Lt cells, and
mAb 11-4.1 (15) was used at a 1/100 dilution to detect H-2Kk on CBA/J cells. For detection
of class II MHC antigens, mAb 26-7-IIS (12) was used at a dilution of 1/80 to detect I-Ak
on CBA/J cells. A.TH anti-ATL (I-A' anti-I-Ak, broadly crossreactive with most standard
class II haplotypes except s) was purchased from Accurate Chemical & Scientific Corp. (West-
bury, NY) and used at a dilution of 1/15 . mAb 28-13-3 and 11-4.1 were used as ascites; 31-3-4S
and 26-7-IIS were used as culture supernatants. For detection of the unique classII molecules
of NOD and NON, AS-3 (anti-I-ANO') and AS-4 (anti-I-ANO") alloantisera were produced
in our laboratory; both exhibited titers greater than 1/400 in microcytotoxicity assay. AS-3
was produced by immunizing (NON/Lt x C3H.HTG/Snj)F, mice with irradiated NOD/Lt
splenocytes and used at a dilution of 1/100. Immunoprecipitation studies demonstrated that
AS-3 was specific for NOD I-A (personal communication, Dr. H . O. McDevitt, Stanford
University Palo Alto, CA). AS-4 was produced by immunizing (NOD/Lt x B6.PL-Thy-1°)F,
mice with irradiated NON/Lt splenocytes and was also used at a 1/100 dilution. Splenic leu-
kocytes from NOD/Lt, NON/Lt, and (NOD x NON)F, mice were phenotyped for cell sur-
face H-2K antigen expression using a FACSCAN cytofluorograph as described previously
(16) . In brief, freshly obtained splenocytes were incubated with or without primary mAbs
28-13-3 (for H-2Kb) and 31-3-4S (for H-2K') for 30 min at 4°C. Cells were washed and in-
cubated another 30 min at 4°C with fluorescein-labeled goat-anti-mouse IgG (GAM). Cells
were stained with 40 ug/ml propidium iodide for analysis of viability, and dead cells were
excluded from the analysis. Splenic B lymphocytes express surface Igs that bind the second
antibody (GAM). Therefore an aliquot of cells from each genotype was stained with GAM
only (no primary mAb) such that positive staining B lymphocytes in each population (Fig.
2, left panels) would be subtracted as background from the staining obtained when primary
mAb was present (Fig. 2, middle and right panels).
M¢ and Islet Cell Cultures.
￿
Peritoneal Mtp were thioglycolate recruited and harvested as
previously described (17). MO were seeded at 5 x 105 cells/ml/well of 24-well plates (Corning)
in DME supplemented with 16.5 mM glucose, 0.02% BSA, MEM nonessential amino acids,
44 mM sodium bicarbonate, 15 mM HEPES, 50 mg/liter gentamicin sulfate, 10% heat-
inactivated FCS, with or without 50 U/ml rat IFN-y, kindly provided by Dr. Peter van de
Meide, T.N.O. Primate Center, Rijswijk, Netherlands. The peritoneal MO were cultured
in the presence or absence of IFN-'Y for 3 d unless otherwise specified. All tissue culture re-
agents were obtained from Gibco Laboratories, Grand Island, NY.
Pancreatic islets were isolated for culture by collagenase digestion as described previously
(18). Whereas CBA/J and NON/Lt islet donors of all ages were used, only young aglycosuric
(6-8-wk-old) NOD/Lt islet donors were used. Hand picked islets were seeded 30/well in 24
well plates and incubated in 1 ml of DME supplemented as described above. Pancreases from
four to five donors per genotype were used per isolation and the islets pooled (-150 islets
picked from each pancreatic digest). After an initial 3-d period in serum-containing medium
during which islet attachment and spreading of cells occurred, serum was omitted for one
or two refeedings as required to inhibit fibroblast growth, with refeeding every 3-4 d until
islets had monolayered (14 d). At day 14, the islet monolayers were refed with medium withLEITER ET AL.
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or without 50 U/ml IFN-,y for 6 d. Cultures were then tested for expression ofMHC antigens
using the chromium-release assay described below.
GeneticAnalysis of"Occult" Gene Expression.
￿
To determine chromosomal localization of a IFN-
inducible crossreactive epitope in NOD/Lt detected by mAb 28-13-3, and suppressed by the
CBA/J inbred background, reciprocal (NOD/Lt x CBA/J)F, hybrids were produced and
peritoneal MO response to IFN-y induction ofthe "occult" locus analyzed. F, mice were back-
crossed to both the NOD/Lt and CBA/J parental strains, and peritoneal Mo were isolated
from 8-12-wk-old first backcross (BCI) progeny. After culture for 3 d in the presence of 50
U/ml IFN-.y, reactivity of these peritoneal Mo with mAb 28-13-3, 31-3-4, and 11-4.1 was as-
sessed using the "Cr-release assay described below. The latter two monoclonals permitted
MHC phenotyping; in the backcross to NOD/Lt, half of the segregants would theoretically
be H-2K° homozygotes and half H-2K°/H-2K' heterozygotes, while in the backcross to
CBA/J, half would be H-2K' homozygotes and half would be H-2Kd/H-2K' heterozygotes.
Chromium-releaseAssays.
￿
Cells to be assayed by complement mediated lysiswere incubated
at 37°C for 90 min in 250 Etl of DME containing 10 JACi/m 51Cr (ICN Biomedical, Inc.,
Irvine, CA). Cells were then rinsed three times with HBSS + 0.1 % BSA. Triplicate cultures
were incubated at 4°C with and without diluted antibodies for 30 min followed by incubation
at 37°C for 3 h with rabbit complement (LowTox-M ; Accurate Chemical & Scientific Corp.,
Westbury, NY) diluted 1/12 . Supernatants were removed to determine radioactivity (cpm)
released. Cells remaining were solubilized in 1% SDS and absorbed with cotton swabs to
determine unreleased radioactivity. Percent release was determined from the equation [cpm
in medium/(cpm in medium + cpm in cells)] x 100%. The cytotoxic index (CI) was ob-
tained from the equation CI = 100% x [[(percent release of antibody + complement) -
(percent release of complement alone)]/[100% - percent release of complement alone]] .
H-2K6 Alloreactive NOD T Cells.
￿
A model system was designed to test the question as to
whether IFN-.y-induced expression ofthe "occult" antigen on NOD/Ltacells could be recog-
nized by NOD alloreactive T cells. Four 6-wk-old NOD/Lt females (H-2KI received weekly
tail vein injections (over 5 wk) of 10' irradiated splenocytes (2,000 rad, "'Cs source) from
an incipient NOD.NON-H-2K6 congenic stock (N6F,). Three unmanipulated NOD/Lt fe-
males served as unprimed controls. T cells were nylon wool purified (16) from splenocytes
of primed and unprimed 11-wk-old NOD females, and 5 x 105 of them were cocultured in
triplicate in flat-bottomed 96-well microtiter plates (Corning) containing 12 islets/well from
NOD.NON-H-2K" (positive controls) or standard (H-2K~ NOD donors. The islets were
pretreated with or without 50 U/ml IFN-,y for the 6 d before coculture with T cells. The
islet-T cell cocultures were incubated for 4 d at 37°C and labeled with 0.5 pC/well
[3H]thymidine (New England Nuclear, Boston, MA) over the final 8 h of incubation. The
cultures were then harvested onto glass fiber disks with a PHD cell harvester (Cambridge
Technology, Cambridge, MA), and the disks were counted in 3 ml of Aquasol-2 (New En-
gland Nuclear). Data are represented as Acpm (the mean cpm of triplicate T cell cultures
in the presence of islets minus the mean response of T cells and islets cultured separately
in medium only). In a separate experiment, 106 T cells isolated from NOD.NON-H-2K'
primed NOD mice were maintained for 2 wk on IFN-.y-pretreated NOD islets in medium
containing 10% Con A-conditioned culture supernatant as a source of exogenous cytokines.
The T cellswere then harvested and seeded in triplicate at 105/well in a 24-well cluster plate
containing islet monolayers from NOaNON-H-2K° or NOD mice that had been precul-
tured with and without IFN-.y before labeling with 5'Cr for 4 h. T cell mediated lysis (CML)
was assessed by "Cr release over a subsequent 4-h incubation period as described above.
Results
IFN-y-inducible Class II MHC In Islets and Mo.
￿
As illustrated in Table I, levels
of constitutive and IFN-y-inducible cell surface expression of class II antigens de-
pended upon type of cells cultured (islet cells vs. peritoneal MO) and inbred strain
background (CBA/J, NON/Lt, NOD/Lt, and F, hybrids). The CBA/J inbred strain
background provided the most striking example oftissue-specific differences in IFN-
y-regulation ofI-A antigen expression. In the absence ofIFN-,y in the culture medium,1246
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TABLE I
IFN-y Induction of MHC Class II in Cultured Islet Monolayers
and Cultured Peritoneal Mo
Cytotoxic index
A.TH anti A.TL antiserum, broadly cross-reactive.
X Indicates values that have not been determined. Cytotoxic indices were obtained from anti-
body plus complement-mediated "Cr-release assays using the mAb or I-A alloantisera rea-
gents described in Materials and Methods. Triplicate wells containing islet cells or Mo cultured
in the presence or absence ofIFN were treated with complement alone or complement plus
antibody and cytotoxic index determined as described in the text.
neither CBA/J islet monolayers cultured for 21 d nor MO cultured for3 d expressed
significant surface I-A' [CI = 0 (CBA/J islets) and 2 (CBA/J MO) using the anti-
I-Ak mAb] . IFN-y elicited I-A' expression on the surfaces of cultured CBA/J MO
(CI = 19), butnot on cultured CBA/J islet cells(CI = 0), indicating atissue-specific
difference in IFN-y regulation ofI-Aantigenexpression within the same inbred strain.
Theimportance ofregulatory genesin the inbred strain background in determining
tissue-specific as well as strain-specific responsiveness to IFN-y was further under-
scored when the NON and NOD backgrounds were studied (Table 1). In contrast
to cultured CBA/J MO, which exhibited IFN-y-inducible, but virtually no consti-
tutive I-Ak expression, cultured NON/Lt and NOD/Lt Mo expressed I-ANON and
I-ANOD class II antigens constitutively. However, a striking difference in level of con-
stitutive expression between NON/Lt MO (CI = 7) and NOD/Lt MO (CI = 51)
was observed (Table I). As was the case with CBA/J MO, I-A expression in NOD/Lt
and NON/Lt Mo was IFN-y inducible (CI = 40 and 71, respectively). Although
the CI of cultured NON/Lt MO was strongly increased by IFN-y, the induced level
was lower than that level constitutively expressed by NOD/Lt MO. On cultured
NON/Lt islet cells, constitutive I-ANON expression (CI = 16) was observed that was
not significantly elevated by IFN-y (CI = 17). Again, islet cultures from NOD/Lt
differed from NON/Lt. Although I-ANOD was inducible on cultured NOD/Lt islet
cell surfaces (CI = 11), it was not constitutively expressed (Table I).
Tissue-specific differences in IFN-y responsiveness within the same inbred strain
were again observed when surface I-ANOD was compared on NOD/Lt islet cells
versus MO (Table I). Although I-ANOD was inducible on the cultured islet cell sur-
faces, it was not constitutively expressed. In contrast, NOD/Lt Map cultures were
Strain IFN-y I-Ak
Islets
I-ANON I-ANOD I-A. I-Ak I-ANON
Macrophages
I-ANOD I-A'
CBA/J - 0 0 0 2 2 0 0 0
+ 0 4 0 1 19 0 0 32
NON/Lt - 0 16 0 0 0 7 4 4
+ 0 17 0 7 0 40 6 32
NOD/Lt - 0 0 0 0 0 0 51 NDt
+ 0 0 11 9 0 0 71 ND
(CBA x NOD)Fj - 0 0 1 0 0 0 25 0
+ 0 0 0 0 25 0 41 43
(NON x NOD)Fj - ND 0 0 0 0 6 49 6
+ ND 11 21 19 0 40 51 46LEITER ET AL.
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constitutively expressing high levels that were only moderately elevated further by
IFN-y (Table I). When Mo cultures from (NON x NOD)Fi hybrids were screened
for expression ofeach parentally derived I-A antigen, both parental patterns ofcon-
stitutive and IFN-y-inducible expression were maintained. Thus, in MO cultured
from the (NON x NOD)Fi hybrid, I-ANON was constitutively low, but strongly
IFN-y inducible as in the NON/Lt parental strain (Table I). Concordant with the
NOD/Lt parental strain, a very high constitutive expression ofI-ANOD was observed
in Mo cultured from the Fi hybrids (Table I). Hence, differences in independent
and apparently cis-active IFN-y response elements controlling I-A gene expression
distinguished the NOD/Lt and NON/Lt inbred strain backgrounds.
Whereas cis-active, IFN-y-sensitiveregulatory elementsofclassIIstructural genes
were independently operative in MO of (NON x NOD)F1 hybrids, a completely
differentregulationwasobserved in islet, but not Mo cultures established from (CBA
x NOD)Fi mice. As already described, parental CBA/J islet cells did not consti-
tutively express I-Ak and expression was not IFN-y inducible, whereas parental
NOD/Lt islet expression of I-ANOD was not constitutive, but was IFN-y inducible.
In islet cells from the Fl hybrids between these two strains, the CBA/J genome in-
teracted ina trans-fashionwiththe NOD/Lt genometosuppress IFN-'Y inducibility
ofI-A" (Table I). Interestingly, this trans-suppressive action ofthe CBA/J genome
on expression ofI-ANOD was islet cell specific, since no similar trans-suppression was
observed in the cultured MO from the F, hybrids (Table I).
All "Cr-release data generated by cytotoxicity assays were confirmed by visual
inspection under phase microscopy of the cultured cells undergoing antibody plus
complement-mediated lysis. At the morphologicallevel, the complete resistance of
IFN-y-treated CBA/J islet monolayers to lysis by anti-I-Al plus complement con-
trasted to IFN-y-treated NOD/Lt monolayers. The latter exhibited clear lysis in
the presence of anti-I-ANOD plus complement (Fig. 1). Previous ultrastructural anal-
ysis of these monolayer islet cell cultures has established that the majority of the
cells (>70%) are glucose-responsive 0 cells(19); intraislet macrophages/dendritic cells
comprise only about 4% or fewer of the cells in these islet monolayers such that
the majority of the cells in Fig. 1 D undergoing extensive antibody plus comple-
ment-mediated cytolysis probably are ,B cells. Thus, IFN-y inducibility ofclass II
antigen on mouse Rcell surfaces is strongly dependentupon the genetic background
ofthe isletdonor strain, with trans-suppressive factor(s) in the CBA/J genome appar-
ently underlying nonresponsiveness to IFN-y.
IFN-y-inducible Class IMHC Gene Expression In Islets and Mo.
￿
Table II compares
the constitutive and IFN-y-inducible cell surface expression of MHC class I an-
tigens as a function ofcell type (islet cell vs. peritoneal MO) and inbred strain back-
ground (CBA/J, NON/Lt, NOD/Lt, and Fi hybrids). Without IFN-y in the cul-
ture medium, CBA/J MO expressed no detectable Kk after 3 d in culture, whereas
expression was maintained in its presence (CI = 46). In contrast, MO from both
NOD/Lt (K~ and NON/Lt (Kb) maintained high constitutive levels of class I ex-
pression (CI = 66 and 71, respectively) following 3 d ofculture in the absence of
IFN-y, with only a slight increase in expression in its presence (CI = 70 and 81,
respectively). Crossing CBA/J (nonconstitutive for class I expression on MO after
3 d in vitro) and NOD/Lt (constitutively expressing after 3 d in vitro) produced
Fl Mo that failed to constitutively express Kk in vitro while continuing to express1248
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FIGURE 1 .
￿
Morphological demonstration of IFN- ,y-induced class II MHC inductionon NOD/Lt,
but not CBA/J islet cell monolayers . No cytolysis observed in CBA/J (I-A k) islet monolayer be-
fore (A) and after (B) treatment with cytolyticmAb 26-7-11S (anti-I-A , CI = 0), and an intact
NOD/Lt islet monolayer before (C) and extensive cytolysis in thesame monolayer after (D) treat-
ment with cytolytic alloantiserum AS-3 (anti-I-ANOD , CI = 9.2) .
Kd constitutively (CI = 45) . This contrasted with the (NON x NOD)F1 hybrids;
the pattern ofclass I expression onMo from these mice was identical to the parental
strains with high constitutive levels of class I and little further induction by IFN-y
treatment (Table II) . Thus, inbred strain-dependent factors regulating expression
ofMHC class I gene products on MO in culture were cis-acting .
The pattern ofexpression ofMHC class I surface antigens on long-term cultured
islet cells as a function of inbred strain background was concordant to expression
of the same antigens on cultured Mo from the same genotypes (Table II) . CBA/J
islet monolayers after 3 wk of culture did not constitutively express Kk, but expres-
sion was IFN-y inducible (CI = 32) . Class I antigens were constitutively expressedLEITER ET AL.
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TABLE II
IFN-,y Induction of MHC Class I Antigens in Cultured Islet
Monolayers and Cultured Peritoneal Mo
` Indicates values that have not been determined. Cytotoxic indices were ob-
tained from antibody plus complement-mediated S'Cr release assays as
described in Materials and Methods.
and were IFN-,y inducible on islet cultures from NOD/Lt and NON/Lt. The levels
ofconstitutive and IFN-y-inducible class I antigen expression on islet monolayers
were lower than observed for Mo of the same genotype, suggesting tissue specific
differences in antigen density. Again, F1 hybrids between the nonconstitutively ex-
pressing CBA/J and constitutively expressing NOD/Lt showed cu-acting regulation
in that the CBA/J H-2K' gene in islet cells from F1 donors was repressed in the ab-
sence of IFN-,y whereas the NOD/Lt H-2K' gene was constitutively expressed in
the absence of IFN-,y and further inducible in its presence.
Demonstration ofan "Occult" Class I-like antigen on NOD/Lt Islets and Mo.
￿
In per-
formingthe analyses depicted inTableII, monolayerculturesofNOD/Lt and CBA/J
islet cells and Mo weretested for reactivity with mAb 28-13-3 as well as other anti-
bodies that should havebeen unreactive (i.e., "irrelevant" mAb). As expected, CBA/J
cells were completely unreactive to mAb 28-13-3 (Table II). Further, as confirmed
by the cytofluorographic analysis shown in Fig. 2, freshly prepared splenic leuko-
cytes from NON/Lt (Kb) or from (NOD x NON)F1 (K'IK~ mice, but not from
NOD/Lt (,ad' mice, specifically bound mAb 28-13-3. Therefore, the finding that
mAb 28-13-3 plus complement was nontoxic to either NOD/Ltislet cells orMO cul-
turedinthe absence ofIFN-,y(CI = 0) wasexpected. Unexpectedly, as documented
in Table II, IFN-,y treatment induced a latent reactivity to mAb 28-13-3 (CI = 27),
indicating induction of a Kb-like "occult" crossreactive antigen presumably mimetic
with public specificity H-2.39. FAGSanalysiswas repeated usingabiotinylated prep-
aration ofmAb 28-13-3 followed by addition ofa FITC-avidin conjugated in an at-
tempt to see if the cross-reactive epitope recognized by this antibody could be ob-
served in the absence of the high B lymphocyte background produced when a
FITC-labeled goat anti-mouse antibody detection system was used with unlabeled
mAb 28-13-3 as a primary antibody. While 86.7% of NON/Lt splenocytes bound
Strain (H-2K) IFN-,y H-2K'
Islets
H-26
Cytotoxic index
Macrophages
H-2d H-2K' H-2Kb H-2Kd
CBA/J - 0 1 2 0 0 0
(Kk) + 32 1 0 46 0 0
NON/Lt - 0 5 1 0 71 0
(Kb) + 0 51 0 2 81 0
NOD/Lt - 0 0 16 0 0 66
(Kd) + 0 27 39 0 43 70
(CBA x NOD)F1 - 0 0 18 0 0 45
(Kk/Kd) + 42 0 40 41 6 56
(NON x NOD)F1 - ND` 17 19 0 64 64
(Kb/Kd) + ND` 48 44 0 70 681250
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FIGURE 2 .
￿
FACS analysis of NOD/Lt, NON/Lt, and(NOD/Lt x NON/Lt) splenic leukocytes
showing specific staining (above GAM-only stained controls) ofuncultured NON/Lt,and(NOD/Lt
x NON/Lt), but not NOD/Lt cells by mAb 28-13-3 . The percentages indicate the number of
positively staining cells to the right of the gated threshold (vertical line) .
the biotinylated reagent, no binding beyond the FITC-avidin control was observed
in freshly-isolated NOD/Lt splenocytes (data not shown) .
The (CBA x NOD)Fi hybrid provided insight into the regulation of this "occult"
gene. As shown in the results presented in Table I and described above, the trans-
active factor(s) emanating from the CBA/J genome were capable of suppressing
I-AND' expression only in (CBA x NOD)F, islet cell cultures, but not in Fl MO cul-
tures (Table 1). Therefore, it was not anticipated that the trans-active factor produced
from theCBA/J genomewould suppress the "occult" crossreactive entity in both islet
andM¢ cultures established from (CBA x NOD)Fi hybrids . Yet this dual suppres-
sion in both cell types was indeed observed (Table II). Therefore, the "occult" locus
appeared to be independently regulated from the standard class I and II loci .
Time Course ofIFN-yInduction of "Occult"us. Class Iand IIAntigens.
￿
The time course
ofIFN-y induction of the occult antigen as detected by mAb 28-13-3 versus the in-
duction curve for the standard MHC class I H-2Kd detected by mAb 31-3-4 is
shown for peritoneal MO in Fig. 3 . These curves clearly established the separate
regulation of the two antigens ; the H-2Kd antigen was constitutively expressed on
M0, and higher levels were induced by IFN-y . Compared with I-ANDI, which had
been significantly induced by 16 h, the "occult" antigen required between 48 and
64 h to be expressed on the cell surfaces . After prolonged culture after removal ofe
c
0
x 0
0
Present
Tlrne (Days)
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FIGURE 3. Time course of
surface antigen induction and
decay on NOD/Lt Mo after a
3-dIFN-,ypulse. NOD/Lt peri-
toneal Mo treated in vitrowith
50 U/ml IFN-.y for3 d, rinsed,
refed, and incubated without
IFN-,y for up to 16 d, were
assayed with antibody plus
complement-mediated "Crre-
lease at various time points for
I-ANOD
(A). H-2Kd (O), and
"occult" antigen (p)expression.
IFN-,y at 72 h, the differential decay rate ofthe constitutively expressed Kd versus
the nonconstitutive but IFN-y-inducible occult antigenis evident. Thus, the occult,
but not the Kd antigen expression in vitro required the continued presence of
IFN-y. Although the induction rates for occult antigen vs. I-ANODwere clearly dis-
tinguishable, the induced levels ofboth antigens appeared to remain stable for N4 d,
and the subsequent decay rates for both were quite similar (Fig. 3). However,
I-ANOD was induced by IFN-y to a higher level than was the occult antigen such
that by culture day 11 (8 d after IFN-,y withdrawal), occult expression had declined
to essentially baseline whereas I-ANOD was still strongly expressed (Fig. 3).
Genetics of Occult Gene Expression on Mo.
￿
As established in Table II, trans-acting
regulatory elements in the CBA/J inbred strain background were capable of sup-
pressing IFN-y-stimulated occult antigen expression in both islet cell and MO cul-
tures from (CBA x NOD)Fi donors. Accordingly, the number of genes and their
potential chromosomal localization couldbe analyzed bybackcrossing IFN-y-nonin-
ducible Ft hybrids to both the NOD/Lt (inducible) and CBA/J (noninducible) pa-
rental strains, and testing BC1 segregants for IFN-y-inducibility ofoccult antigen.
The results of"Cr-release assay using mAb 28-13-3 plus complement are presented
in Fig. 4 and clearly establish that the structural gene for the occult locus is tightly
linked to the MHC of NOD mice (Chr 17). The data obtained from backcross to
NOD/Lt further indicate that trans-suppressors contributed by the CBA/J genome
may be under polygenic control. Chromium-release assay produced a mean CI of
43 for IFN-y-cultured NOD/Lt Mo versus a mean CI of 1.1 for CBA/J and CI
of 6 for the Fl. Mice backcrossed to NOD/Lt (D/BC1) and CBA/J (C/BC1) were
phenotyped with mAbs for H-2K antigen, and this was correlated with the level
of occult crossreactivity with 28-13-3. D/BC1 mice homozygous for the NOD Chr
17 marker (K~ had ahigh NOD/Lt-like value (mean CI = 43.9); interestingly, 5/19
ofthis group had a high intermediate level of expression, suggesting that at least
one otherco-dominant regulatory locus was segregating(Fig. 4). IFN-y-treated MO
from D/BC1 mice heterozygous at the H-2K locus (Kk/K~ exhibited a range of1252
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FIGURE 4.
￿
Genetics of occult gene expression on peritoneal Mo from first backcross mice to
NOD(D/BCI)or CBA (C/BCl) showinglinkage ofthe structural locusto Chr 17 ofNOD. Com-
plement + mAb 28-13-3 (anti-H-2Kb)-mediated 5ICr release wasused to determine the varying
levels ofoccult antigen expression inducedon thesurfaceofMO treatedfor3 dwith 50 U/ml IFN-.y.
values from intermediate, to low FI-like values (mean CI = 11.8), further indicating
linkageofthe structural locus forthe occult antigento theMHC ofNOD. The local-
izationofthe occult locus toChr 17 ofNOD/Lt was confirmedin C/BC1 mice since
no Mo cultures derived from the K'k homozygous segregants expressed IFN-'y-in-
ducible occult antigen. Occult expression was observed to varyingdegrees in C/BC1
mice thatwere heterozygous atthe H-2K locus. ThemeanCI of12.9in Mo isolated
from these mice was almost the same as that observed in the Kd/K' k heterozygous
DBC1 segregants (Fig. 4). Although theoccult-suppressive nature ofCBA/Jmodifiers
in the Fl suggested that they were dominant in action, the wide variation in CI
values in the MHC heterozygous D/BC1 and C/BC1 segregants (from low "Fl"-like
to high intermediate levels) suggestedthatCBA-mediated suppression was polygenic
in nature. That the CI in Kd/K' heterozygotes was usually considerably less than
5070 of that observed in Kd/K' homozygotes suggested that more than an occult
structural gene dosage effect was involved.
Since Moharvesting fromBC1 mice was a nonlethal procedure, the MO cultures
could be used to MHC-type the mice and establish their level ofoccult inducibility.
Fromthis characterized segregant population, representative individuals were killed,
and their pancreatic islets were isolated and placed into culture. Levels of occult
expression on these islet monolayers treated with IFN-y could thus be compared
with the pervious data obtained from Mo from the same mouse. As shown by the
morphological datapresented in Fig. 5, the CI foroccult antigen expression gener-
allycorroborated thedata obtained for Mo from the same mice. As shown in Table
I, maximal CIfrom UN-y-culturedNOD/Lt isletsinresponse to mAb28-13-3duringFIGURE 5 .
￿
[(CBA/J x NOD/Lt)F, x NOD/Lt]BC1 islet monolayers before and after treatment
with mAb 28-13-3 (anti-H-2Kh) and complement in an assay for occult antigen expression . (A
and B). Before and after treatment of an islet monolayer from a KdlK'tMHC heterozygote who
had previously donated MO yielding alow CI of 7.0 (i .e., trans-suppressed for occult) . There is
visual evidence of only slight islet cell destruction, as confirmed by an islet CI of 4.2 . (C and
D) . Before and after treatment of an islet monolayer from aKd/Kk MHC heterozygote who had
previously donatedM¢ yielding an intermediate CI of 17 .4 (i .e., incomplete trans-suppression
ofoccult). Clear visual evidence of islet cell destruction, confirming an isletCI of 13.2, is evident .
(E and F) . Before and after treatment of an islet monolayer from a KdlKd MHC homozygote
whohad previously donated MO yielding an high NOD/Lt-like CI of44 .6 (i .e ., no trans-suppression
ofoccult) . Clear visual evidence of islet cell destruction, confirming an islet CI of 16.4, is again
evident .1254
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a 3-h lysis period was only 27 in comparison to a CI of 43 from Mo over the same
time period . Interestingly, the lower CI for islets appeared to represent an inherent
property of the islet cultures . As shown in Fig. 5, more visual evidence of islet cell
destruction was documented by phase microscopy of islets from aKd homozygous
donor (whose Mo exhibited a CI of 44.6) than from aKdlK't) heterozygous donor
(whose MO yielded a CI of 17.4) . Yet when compared with a CI difference of 27 .2
between the two MO populations, only a 3.1% difference in CI was observed be-
tweenthetwo islet populationsdepicted (Fig . 5Dvs . F), despite the visual evidence
of greater lysis from the Kd homozygous cell population .
Can TCells Recognize Occult Antigen on NOD/Lt Islet Cells?
￿
Expression oftheoccult
antigen on NOD/Lt pancreatic a cells could play a role in disease pathogenesis if
recognized byT cells. This possibility was investigated by examining the ability of
T cells from NOD/Lt mice to respond to IFN-y-treated NOD/Lt islets following
priming with splenocytes from an incipient NOD/Lt congenic stock homozygous
for H-2K' (and thus expressing public specificity H-2.39 that is mimetic with the
occult antigen) . As shown in Fig . 6, T cells fromNOD mice that had been primed
to H-2Kb only responded blastogenically to NOD/Lt islets that had been precul-
turedwith IFN-y, but not NOD/Lt islets precultured in medium only. Theprimed
T cell population also responded blastogenically to Kb antigen-expressing islets iso-
lated from thecongenic and precultured either in the presence or absence ofIFN-y .
Both Kb antigen-primed and unprimed NOD/Lt T cells responded to congenic
islets expressing the Kb antigen, indicating the congenic islets were capable of
stimulating primary allogeneic responses . The response of unprimed NOD/Lt T
cells to IFN-y precultured NOD/Lt islets was similar to the Kb-primed NOD/Lt
T cell response to NOD/Lt islets precultured in the absence ofIFN-y. Collectively,
these results indicated that priming of NOD/Lt T cells to Kb resulted in a T cell
population capable of responding blastogenically to NOD/Lt islets expressing the
IFN-y inducible occult antigen . In a separate experiment,Kb primed NOD/Lt T
cells were incubated with IFN-y pretreated NOD/Lt islets for 2 wk in the presence
ofCon A-conditioned CBA/J splenocyte culture supernatant as a source of exoge-
nous help . T cells from this culture were then added at 105/well to triplicate cul-
tures of "Cr-labeled NOD/Lt islets that had been pretreated in the presence or ab-
sence of IFN-y . These T cells elicited a significantly higher 5'Cr release from
FIGURE 6.
￿
NOD.NON-H-2K6 primed T cells
respond blastogenically to IFN-y precultured
NOD islets. Nylon wool-purifiedTcells from un-
primed NOD/Lt or NOD/Lt mice primed five
times with splenocytes from NOD.NON-H-2K'
congenic were added in triplicate at 5 x 105 to
islets isolated from the congenic or standard
NOD/Lt mice and precultured in the presence
or absence of IFN-y . The cultures were labeled
with 0.5 uCi/well [ 3H]thymidine over the final
8 h of a 4-d incubation .LEITER ET AL.
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NOD/Lt islets pretreated with IFN-y (CI = 10.3 t 0.9) than from islets precul-
tured in medium only (CI = 0). Collectively, these results indicate that NOD/Lt
T cells primed to Kb could recognize the occult antigen expressed on NOD/Lt islets.
Discussion
The unexpected discovery ofacytokine-inducible cell surface antigen on cultured
NOD/Lt islet cells suggested a potential pathogenetic triggeringmechanism to acti-
vate autoimmune Tcells. One of the puzzling aspects ofdiabetes pathogenesis in
NOD mice has been thatpancreatic leukocytic infiltrates appear shortlyafterweaning
(3-5 wkofage), butinsulitis does not become severe enough to effect a majorreduc-
tion in/3 cellmass and islet insulin contentuntil after 12 wk (20). IFN-'Y is aproduct
ofT cells. It is conceivable thatwhen a critical mass ofperiinsular Tcells and other
leukocytes is accumulated, cytokines such as IFN-y lead to induction ofheretofore
silent genes such as the one encoding the MHC-linked occult antigen described in
this report. It is noteworthy in this regard that Janeway et al. have proposed the
existence ofa population ofT cells (TCR1, expressing rearranged S/yTcell receptor
chains) whose function may be surveillance ofthe integrity ofepithelial cells (21).
The major function proposed for activated TCR1 cells is the destruction ofinjured
or otherwise altered epithelial cells, and there is evidence that recognition of, and
response to class I-like MHC gene products maybe integral to the activation cycle
(21). The present study has demonstrated that NOD/Lt T cells primed tothe H-2Kb
alloantigen were not stimulated by untreated islet cultures from standard NOD/Lt
donors (H-2K~. However, when replicate cultures of islets from the same donors
had been precultured in IFN-y to elicit occult antigen expression, the anti-H-2Kb
primed T cells were either stimulated to proliferate in one experiment (Fig. 6) or
to mediate antiislet cytotoxicity in a second experiment. The implication of these
model studies in vitro is that if high levels of occult were expressed in situ, an im-
munogenic response might be anticipated. Our studies further demonstrated that
IFN-y not only stimulated expression ofthe occult antigen on NOD/Lt (3 cells, but
also class I and class II MHC molecules. Ifthe occult antigen can be recognized
by T cells expressing rearranged ct,a TCR chains (TCR 2 as proposed in [21]), the
induction of standard MHC molecules on the pancreatic a cell surface could serve
as restriction elements for presentation ofthe occult antigen. Pujol-Borrell and Bot-
tazzo have recently proposed that tolerance to rare (low concentration) epithelial
cell autoantigens is maintained by lack of efficient autoantigen presentation (22).
The presentation oftheoccult antigen to TCR 2 cells by self-MHC may thus occur
in a mannersimilar to thepresentation ofminorhistocompatability antigens. How-
ever, recent studies with I-Eadob-expressing transgenic islet cells suggest that class
II MHC gene products on the surface of (3 cells imparts T cell anergy rather than
activation (23). Alternatively, as discussed above, TCRI T cells have been proposed
to play a role in surveillance of epithelia by responding in a non-MHC-restricted
fashion to MHC class I like genes induced on epithelial cell surfaces by viral infec-
tion orother injury (21). Activation ofendogenous retroviruses in pancreatic (3 cells
has been associated with the development of insulitis and diabetes in NOD mice
(24). The activation ofthese endogenous viruses may result in IFN-'Y synthesis with
subsequent induction ofthe occult antigen on pancreatic (3 cells leadingto theirelimi-
nation by TCRI cells.1256
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The genetic analysis of occult gene expression in Mo and islets strongly suggested
that the structural gene for this locus was MHC-linked. In mice, in addition to the
3-6 class I genes within the MHC complex on Chr 17 encoding the classical trans-
plantation antigens, there are 20-30 distinct class I-like genes with open reading
frames localized to the TL complex distal to the H-2L marker locus of the MHC
(25). The TL complex is subdivided into two regions, Qa2 and TL . Qa-2 is a sero-
logically defined polypeptide primarily expressed on cells of hematopoietic origin ;
it has been established that the Q7 locus within the Qa2 region of the TL complex
encodes both amembrane bound as well as asecreted polypeptideindistinguishable
from the Qa-2 antigen (26, 27). The allodeterminant on H-2Kb molecules recog-
nized by mAb 28-13-3 apparently resides in the second external (C1) domain (9);
comparison ofthe gene sequence coding for this domain versus the sequence coding
for the same domain in the Q76 locus of C57BL/10 revealed 87% homology (only
37 of 276 nucleotides discordant [27]). Although NOD/Lt lymphocytes have not
yet been typed to determine whether they are high level expressors of Qa-2, they
have in common the H-2D6 allele associated with high expression in the C57BL/10J
and C57BL/6J strains. Indeed, restriction fragment analysis of DNA using a H-2K
probe that crosshybridizes with Q7/Q9 has shown a Q76/Q96 restriction fragment pat-
tern in NOD identical to that of Qa-2 high expression C57BL/6J mice, but distinct
from low-expressing BALB/c mice (Lund, T, Dept. of Immunology, University Col-
lege, London; personal communication). The Q76/Q96 genes both encode a soluble
M, 39,000 protein (27). Preliminary mAb 28-13-3 immunoprecipitation studies of
[35S]methionine-labeled NOD/Lt MO lysates have been performed in our labora-
tory. Autoradiographic analysis of an SDS-PAGE gel showed an IFN-,y-inducible
35,000 Mr protein that potentially could represent a biosynthetic form of the oc-
cult antigen. The differences in molecular weightswould suggestthat theoccult pro-
tein is not identical to the product of Qa76. However, enzymatic removal of two
N-linked carbohydrate chains from Qa76- or Qa96-encoded polypeptides did yield
a molecule of M, "34,000 (27) such that the occult antigen might represent a less
glycosylated form. If so, an important distinction still differentiates occult antigen
from the Qa-2 polypeptides, and that is the lack of expression ofoccult on unstimu-
lated splenic leukocytes as assessed by FAGS (Fig. 2).
The occult antigen described in this report may also represent gene products of
the hematopoietic histocompatability-1 (Hh-1) locus that has been mapped to chro-
mosome 17 in linkage with the H-2D locus (28). Unlike standard MHC antigens
that are codominantly expressed, trans-acting regulatory elements suppress expres-
sion of Hh antigen in F, hybrids prepared between Hh antigen-expressing and
nonexpressing parental strains. A trans-regulatory gene model was proposed where
the presence of a regulatory sequence blocked expression of particular Hh deter-
minants, while the absence of the regulatory sequence allowed for gene expression.
The suppression of Hh-1 gene expression in Fl hybrids is proposed to play a role
in the resistance of these hybrids to reconstitution with bone marrow from the pa-
rental strain expressing the Hh antigen. Thus, the regulation of Hh-1 gene expres-
sion follows the same pattern as expression of the occult antigen. Since the Hh-1
locus is apparently in tight linkage with H-2D it is tempting to speculate that Hh-1
may be oneof the class I genes that have been mapped to theH-2D locus in addition
to the standard H-2D gene. Like the occult antigen in this report, the products ofLEITER ET AL.
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these genes (D2, D3, andD4) have recently been demonstrated to becapableo£being
recognized by CTL (29). Other genes with low polymorphism, but with broad ex-
pression in epithelial tissues have been reported (30) such that the exact identity
of the structural gene encoding the occult antigen remains to be determined.
The functions ofthe class I-like antigens encoded in the Qa/TL region remain
obscure; expression of Qa-2 antigen has been reported on mouse preimplantation
embryos up to blastocyst stage (31). Since not all mouse strains express the Qa-2
antigen, embryonic expression is not obligatory for normal development. However,
it is conceivable that there is a developmental interaction between certain MHC
class II alleles such as theunique I-AOallele expressedby NOD mice (32) and QaITL
gene products. Indeed, such interactions could conceivably underlie heretofore un-
explained phenomena such as thereported transmission biasof "diabetogenic" HLA-
DR-associated alleles to offspring of diabetic sires (33).
Regardless ofthe role, ifany, for the NOD occult locus in diabetes pathogenesis,
it represents a valuable tool for analyzing how cis- and trans-acting genomic factors
combine to regulate an IFN-y-responsive gene in an epithelial cell. Both cis- and
trans-acting regulatory elements have been defined in IFN-y induction of murine
class I and II MHC gene transcription, with multiple cis-acting elements usually
associated with consensus sequences located 5' to the class I and II structural genes
(34). Cis-acting element(s) apparently were responsible for the ability ofNOD/Lt,
but not CBA/J, islet or Mo to maintain significant constitutive levels ofH-2K an-
tigen in culture in the absence of IFN-y (Table 1). Important nucleotide sequence
differences have been demonstrated in the upstream IFN-y consensus sequences of
human HLA-A3 and B7 class I genes (35), such that the inbred strain difference
in ability to maintain class I gene expression in culture may well indicate structural
differences in regulatory protein binding sites on the DNA transcriptional control
elements (X and Y boxes). That the strain differences in levels ofconstitutive and
IFN-y-inducible class I surface antigen were not due to qualitative differences in
nuclear regulatory proteins was suggested by the data from F, cell cultures. The
data showed that the markedly different patterns ofconstitutive and IFN--y-induc-
ible class I antigen expression characteristic ofeachparental strain were co-expressed
in F, cell cultures (Table I). Green et al. (36) have reported that failure ofIFN-y
to induce Kk in a mouse tumor cell line was likely due to an alteration cis to the
Kk gene rather than to the presence of trans-acting negative suppressors of tran-
scription.
Tissue-specific (MO vs. islet cell) variation in IFN-y-response elements of class
II genes was consistent with a study indicating that transcription from these genes
in most nonleukocytic cells may normallybe underactive suppression, possibly medi-
ated by IFN-a/(3 (37-39). Fi data in the present study suggested qualitative differ-
ences in trans-suppressive proteins regulating IFN-y-inducedclass II andoccult gene
transcription (Table I). Atrans-actingfactor emanatingfrom theCBA/J genomecom-
pletely suppressed both constitutive and IFN-y-inducible I-A antigen expression
in(3cells(but not MO), and in addition suppressed, inaseeminglydominant fashion,
IFN-y-inducible occult antigen expression in both cultured F, S cells and Met.
Thus, control of IFN-y regulation of class II and occult gene expression could be
dissociated, with levels ofexpression ofthe occult locus conveniently markingpres-
ence or absence of CBA-derived trans-suppressive factors.1258
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Fig. 3 shows that mAb 28-13-3 was not crossreactingwith the standard NODMHC
class I gene products under our culture conditions since 17 d after withdrawal of
IFN-y, cultured NOD macrophages continued to express high levels ofH-2K' (de-
tected with mAb 31-3-4), while the IFN-y-induced occult antigen expression had
decayed to zero. This demonstrates that mAb 28-13-3 is not binding to an epitope
on a standardMHC class I molecule. The extended intervalofbetween 48and 64 h
before the occult antigen appeared on the surface of IFN-y-treated MO as com-
pared to the more rapid appearance ofI-ANOD (Fig. 3) suggested that an interplay
of regulatory genes was necessary before the occult gene was transcribed and final
product could be detected on the surface of Mo. IFN-y stimulation of surface I-A
and occult antigens in the long-term cultures used in the present study probably
entailed a combination ofincreased mRNA transcription, mRNA stabilization (as
evidenced by pulse-chase study), and possibly even posttranslationaleffects. Consti-
tutive class II expression in mouse B lymphocytes is under the control of at least
onedominant locus, Air-1 (activator ofimmuneresponse genes) on Chr 16 encoding
a trans-acting diffusable factor (40). The CBA/J genetic background prevented acti-
vation of IFN-y-responsive elements controlling class II expression in ,l3 cells. The
genetic basis for this remains under investigation; results ofthe genetic analysis for
control of occult gene expression in Mo suggest that at least one co-dominant and
non-MHC-linked autosomal gene inherited from CBA/J is involved.
In conclusion, this study provides a basis for understanding the wide variations
reported inthe literature in IFN-y inducibility ofclass II MHC antigens onmurine
a cells. Inducibility is not an intrinsic property ofall mousea cells, but insteadde-
pends upon strain background-determined presence orabsenceofresponse modifying
genes. The observation that IFN-y elicits expression ofalocus foraclass I-like gene
thatmayserve as arecognitionelement foran immune surveillancecell is ofinterest
in view of the demonstration of a diabetogenic gene on Chr 17 (Idd-11) whose ac-
tionis recessive(41). As mentioned previously, theI-Agene productofNODisunique
and may contribute todiabetogenesis (32). In addition, lack ofexpression ofan PE
gene product has also been reported to control insulitis in NOD mice (42). The
IFN-y-inducible occult locus adds yet another candidate locus on Chr 17 whose
expression may influence diabetogenesis.
Summary
This study provides abasis for understanding the wide variations reported in the
literature in IFN-yinducibility ofclass II MHC antigens on murine /3cells. Induc-
ibility is not an intrinsic property ofall mouse S cells, but instead depends upon
strain- (and tissue-) specific responsemodifying factors. This was demonstrated by
comparison ofconstitutive andIFN-y-inducedclassI and class IIMHC gene prod-
ucts on cultured islet cell monolayers. Islet cultures were established from autoim-
mune diabetes-prone NOD/Lt mice, diabetes-resistant NON/Lt and CBA/J mice,
as well as Fl hybrids between these latter two strains and NOD/Lt. Cultures ofperi-
toneal macrophages (MO)from each strain were established ascontrols. After 3 wk
of culture (with incubation in the presence or absence ofIFN-'r during the last 6
d), constitutive expression as well as IFN-y induction of class I MHC antigen ex-
pression was demonstrated on NOD/Lt and NON/Lt islet cells by antibody plus
complement-mediated cytotoxicity. Although CBA/J islets and Mo did not main-LEITER ET AL.
￿
1259
tain constitutive class I or class II antigen expression in culture in the absence of
IFN-'y, class I H-2Kk antigen was IFN--y inducible. Whereas IFN-'Y-induced class
II I-Ak antigen on CBA/J M0, it failed to induce this antigen on CBA/J islets. In
contrast, I-A antigens were IFN-,y inducible on NOD/Lt and NON/Lt islets and
Map. In (CBA x NOD)Fi hybrids, loss of IFN-,y inducibility of the I-ANOD product
established that suppression was mediated by a trans-acting factor from the CBA/J
genome.
In the course of these studies, IFN-,y inducibility of a crossreactive occult class
I-like antigenon both NOD/Lt isletcell and Mo cultures wasunexpectedly detected
when mAb 28-13-3 (public specificity 39, reactive with H-2K6.) was used as anega-
tive control. Although not detectable by cytofluorographic analysis of freshly iso-
latedNOD/Lt splenicleukocytes, occult antigencouldbe induced on NOD/Lt peri-
toneal macrophages (MO) cultured for3 d in IFN-y. Time course ofinduction showed
the occult antigento be distinct from NOD/Lt class I andII gene products. In both
islet cell and Mo cultures established from (CBA x NOD)Fi hybrids, trans-
suppressive factor(s) from the CBA/J genome not only suppressed IFN-,y-induced
expression of I-ANOD, but additionally suppressed occult antigen induction. Back-
cross of Fl to both parental strains indicated that the occult locus was on Chr 17,
tightly linked to MHC. Polygenic control of IFN-,y responsiveness was indicated,
and the possibility that the inducible antigen may be encoded by a Qa-like gene was
discussed.
Diabetogenesis in NODmice entails aT lymphocyte-mediated destruction of pan-
creatic(3 cells. Although insulitis is an histopathologic feature of diabetogenesis de-
tected shortly after weaning, erosion of pancreatic insulin content is not observed
until several months thereafter. Insulin content does not decline gradually, but ap-
pearsto drop precipitously. Lymphokines such as IFN-,y from infiltrating cellscould
induce a cell expression of surface proteins, including MHC antigens, that may in
turn activate cytotoxic effector cells. We have demonstrated the potential for such
an interaction in vitro. NOD/Lt T cells primed in vivo to splenocytes from a
NOD.NON-H-2Kb congenic stock proliferated in vitro in response to IFN-y-treated
NODislets butnotuntreatedNODislets. This model system suggests theinteresting
possibility that accumulation of IFN-,y around NOD /3 cells in situ could trigger
activation of NOD T cells via induction of occult antigen on /3 cell surfaces.
Receivedfor publication 21 February 1989 and in revisedform 6July 1989.
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